I noticed another company also working on RP. Last update seemed to be a year ago so nit sure how they are progressing now.
https://www.gensight-biologics.com/2020/04/14/gensight-biologics-announces-positive-data-safety-monitoring-board-review-of-pioneer-phase-i-ii-trial-of-gs030-combining-gene-therapy-and-optogenetics-for-the-treatment-of-retinitis-pigmentosa/
Could this be relevant to us?, page-10
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $318.6K | 1.784M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 329917 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 671294 | 8 |
View Market Depth
| Last trade - 10.38am 27/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |